Associated Papers
Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases.
Pertesi M et al.
Leukemia, 2026
41254116 (PubMed )
Supplement: 41375_2025_2802_MOESM1_ESM.pdf
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome.
Todoerti K et al.
Haematologica, 2022
33951891 (PubMed )
Supplement: 2021_278342_TODOERTI_SUPPL.pdf
The RNA Exosome and Human Disease.
Fasken MB et al.
Methods in Molecular Biology (clifton, N.j.), 2020
Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites.
Nassar AH et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2019
30593515 (PubMed )
Supplement: 10780432ccr183147-sup-209386_2_supp_5192871_ptz639.xlsx › S1.3_Raw_SNV_and_small_indels
Multiple Myeloma Genomics: A Systematic Review.
Weaver CJ et al.
Seminars in Oncology Nursing, 2017
Patterns and functional implications of rare germline variants across 12 cancer types.
Lu C et al.
Nature Communications, 2015
26689913 (PubMed )
Supplement: ncomms10086-s13.xlsx › supplementary_data_12
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias.
Lionetti M et al.
Oncotarget, 2015
Select a paper to view details